| Filed On | Filing |
|---|---|
| 30 Jun 2025 |
Form 3: Zambito Michael Sikoryak, Chief Financial Officer
Holds 0 shares of ACTG Common Stock |
| 22 May 2024 |
Form 3: Felman Michelle, Director
No securities owned |
| 15 Feb 2024 |
Form 3: Sundar Ajay, Director
No securities owned |
| 23 May 2023 |
Form 3: Ribar Geoffrey G, Director
No securities owned |
| 17 May 2023 |
Form 3: Rasamny Robert, Chief Administrative Officer
No securities owned |
| 08 Nov 2022 |
Form 3: Molinelli Gavin, Director
No securities owned |
| 08 Nov 2022 |
Form 3: Starboard Principal Co Lp, 10% owner and 3 others
Holds 2,703,404 shares of Common Stock, par value $0.001 per share |
| 08 Nov 2022 |
Form 3: Starboard Value Lp, 10% owner and 9 others
Holds 2,703,404 shares of Common Stock, par value $0.001 per share |
| 29 Apr 2022 |
Form 3: Hoover Kirsten, Controller
Holds 30,000 shares of ACTG Common Stock |
| 15 Mar 2022 |
Form 3: McNulty Martin D. Jr., COO & Head of M&A
No securities owned |
| 22 Nov 2021 |
Form 3: Golby Lawrence Wesley, Director of Research
Holds 80,000 shares of ACTG Common Stock |
| 18 Mar 2021 |
Form 3: Soncini Jason W., General Counsel
No securities owned |
| 09 Jun 2020 |
Form 3: Acacia Research Corp, 10% owner · Evofem Biosciences Inc
Holds 9,139,504 shares of Common Stock, par value $0.0001 per share |
| 04 Jun 2020 |
Form 3: Simmons Meredith A., General Counsel
Holds 0 shares of No Securities Beneficially Owned Directly or Indirectly |
| 04 Jun 2020 |
Form 3: Rosenstein Richard Jay, Chief Financial Officer
Holds 0 shares of No Securities Beneficially Owned Directly or Indirectly |
| 27 Nov 2019 |
Form 3: Sagal Jonathan, Director
No securities owned |
| 18 Nov 2019 |
Form 3: Acacia Research Corp, Director · Drive Shack Inc.
No securities owned |
| 13 May 2019 |
Form 3: Rinaldini Luis E., Director
No securities owned |
| 13 May 2019 |
Form 3: Kohlberg Isaac T., Director
No securities owned |
| 25 Jan 2019 |
Form 3: Oconnell Maureen, Director
No securities owned |
Loading...
